Literature DB >> 20846496

Endotoxin-induced renal tolerance against ischemia and reperfusion injury is removed by iNOS, but not eNOS, gene-deletion.

Jee In Kim1, Hee-Seong Jang, Kwon Moo Park.   

Abstract

Endotoxin including lipopolysaccharide (LPS) confers organ tolerance against subsequent challenge by ischemia and reperfusion (I/R) insult. The mechanisms underlying this powerful adaptive defense remain to be defined. Therefore, in this study we attempted to determine whether nitric oxide (NO) and its associated enzymes, inducible NOS (iNOS) and endothelial NOS (eNOS, a constitutive NOS), are associated with LPS-induced renal tolerance against I/R injury, using iNOS (iNOS knock-out) or eNOS (eNOS knock-out) gene-deleted mice. A systemic low dose of LPS pretreatment protected kidney against I/R injury. LPS treatment increased the activity and expression of iNOS, but not eNOS, in kidney tissue. LPS pretreatment in iNOS, but not eNOS, knock-out mice did not protect kidney against I/R injury. In conclusion, the kidney tolerance to I/R injury conferred by pretreatment with LPS is mediated by increased expression and activation of iNOS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846496     DOI: 10.5483/BMBRep.2010.43.9.629

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  7 in total

1.  LPS ameliorates renal ischemia/reperfusion injury via Hsp27 up-regulation.

Authors:  Kang He; Lei Xia; Jianjun Zhang
Journal:  Int Urol Nephrol       Date:  2017-11-09       Impact factor: 2.370

2.  Glucocorticoid receptor agonist dexamethasone attenuates renal ischemia/reperfusion injury by up-regulating eNOS/iNOS.

Authors:  Jiong Zhang; Jun-Hua Li; Le Wang; Min Han; Fang Xiao; Xiao-Qin Lan; Yue-Qiang Li; Gang Xu; Ying Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

3.  Preconditioning with physiological levels of ethanol protect kidney against ischemia/reperfusion injury by modulating oxidative stress.

Authors:  Qing Yuan; Shanjuan Hong; Shu Han; Li Zeng; Fang Liu; Guoshan Ding; Yindong Kang; Jingyan Mao; Ming Cai; Youhua Zhu; Quan-Xing Wang
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

4.  A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusion.

Authors:  Fausto Chiazza; Konstantin Chegaev; Mara Rogazzo; Juan C Cutrin; Elisa Benetti; Loretta Lazzarato; Roberta Fruttero; Massimo Collino
Journal:  Oxid Med Cell Longev       Date:  2015-03-05       Impact factor: 6.543

5.  Enhancement of potency and stability of human extracellular superoxide dismutase.

Authors:  Sunghwan Kim; Hae-Young Kim; Jung-Ho Kim; Jung-Hye Choi; Won-Kook Ham; Yoon-Jae Jeon; Hara Kang; Tae-Yoon Kim
Journal:  BMB Rep       Date:  2015-02       Impact factor: 4.778

6.  Calycosin-7-O-β-D-glucoside promotes oxidative stress-induced cytoskeleton reorganization through integrin-linked kinase signaling pathway in vascular endothelial cells.

Authors:  Yue-Hua Jiang; Wei Sun; Wei Li; Hong-Zhen Hu; Le Zhou; Hui-Hui Jiang; Jing-Xin Xu
Journal:  BMC Complement Altern Med       Date:  2015-09-07       Impact factor: 3.659

7.  Effect of NADPH oxidase inhibitor-apocynin on the expression of Src homology-2 domain-containing phosphatase-1 (SHP-1) exposed renal ischemia/reperfusion injury in rats.

Authors:  Zhiming Li; Yumei Wang
Journal:  Toxicol Rep       Date:  2015-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.